2026 Q2 Portfolio Activity
In 2026 Q2, SPHERA FUNDS MANAGEMENT LTD. maintained a portfolio of 123 distinct positions. The most significant new addition was INSMED INC, now representing 1.65% of the total fund value. They heavily accumulated shares in CYTOKINETICS INC, increasing the position by 452.5%. The fund also reduced its exposure to NOVA LTD by 52.8%.
Position History
hover any row below to update
Loading…
Total Positions
123
Quarter
2026 Q2
Top Holding
TEVA (6.6%)
Top 10 Concentration
34.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 123
SPHERA FUNDS MANAGEMENT LTD. Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TEVA
TEVA PHARMACEUT...
|
Healthcare | 6.63% | 5.44% |
#1
1
Prev: #2
|
7.2 |
—
|
363,107 | 31.9% |
P
S
|
1,500,082 | $50,822,778 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 5.17% | 5.76% |
#2
1
Prev: #1
|
5.6 |
—
|
130,000 | 9.7% |
P
S
|
1,469,971 | $39,659,818 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TSEM
TOWER SEMICONDU...
|
Technology | 3.68% | 4.06% |
#3
Prev: #3
|
2.5 |
—
|
-37,470 | -25.7% |
P
S
|
108,265 | $28,218,190 | 2016 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 3.10% | 4.06% |
#4
Prev: #4
|
1.7 |
—
|
-50,000 | -25.0% |
P
S
|
150,000 | $23,737,500 | 2017 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 2.89% | 2.69% |
#5
5
Prev: #10
|
4.2 |
—
|
290,043 | 40.0% |
P
S
|
1,014,606 | $22,179,287 | 2016 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIIB
CALL
BIOGEN INC
|
CALL Option | 2.82% | — |
#6
Prev: #—
|
4.6 |
—
|
100,000 | — |
NEW
|
100,000 | $21,606,000 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 2.72% | 2.69% |
#7
1
Prev: #8
|
1.6 |
—
|
4,100 | 4.4% |
P
S
|
96,626 | $20,877,014 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 2.56% | 2.69% |
#8
1
Prev: #9
|
1.0 |
—
|
-220,839 | -27.3% |
P
S
|
588,494 | $19,649,815 | 2015 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 2.45% | 1.26% |
#9
12
Prev: #21
|
4.0 |
—
|
188,650 | 134.8% |
P
S
|
328,550 | $18,799,631 | 2014 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 2.44% | 0.42% |
#10
62
Prev: #72
|
4.0 |
—
|
180,170 | 452.5% |
P
S
|
219,987 | $18,740,693 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 2.38% | 2.89% |
#11
5
Prev: #6
|
1.5 |
—
|
100 | 0.0% |
P
S
|
245,346 | $18,273,370 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.32% | 2.54% |
#12
1
Prev: #11
|
2.9 |
—
|
43,000 | 10.3% |
P
S
|
459,340 | $17,776,458 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVMI
NOVA LTD
|
Technology | 1.78% | 3.68% |
#13
8
Prev: #5
|
0.7 |
—
|
-28,197 | -52.8% |
P
S
|
25,169 | $13,665,257 | 2014 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
INSMED INC
|
Healthcare | 1.65% | — |
#14
Prev: #—
|
4.2 |
—
|
118,800 | — |
NEW
|
118,800 | $12,666,456 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 1.63% | 1.08% |
#15
17
Prev: #32
|
3.7 |
—
|
190,221 | 83.7% |
P
S
|
417,564 | $12,460,110 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AZNCF
ASTRAZENECA PLC
|
Unknown | 1.55% | 1.96% |
#16
3
Prev: #13
|
1.6 |
—
|
no change | no change |
P
S
|
62,530 | $11,856,939 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SNY
SANOFI SA
|
Healthcare | 1.50% | 2.06% |
#17
5
Prev: #12
|
1.6 |
—
|
no change | no change |
P
S
|
269,515 | $11,497,510 | 2014 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYBN
CYBIN INC
|
Unknown | 1.40% | 0.75% |
#18
30
Prev: #48
|
3.6 |
—
|
633,663 | 64.2% |
P
S
|
1,620,753 | $10,713,177 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 1.26% | 1.32% |
#19
1
Prev: #18
|
1.0 |
—
|
-1,000 | -11.1% |
P
S
|
8,040 | $9,643,417 | 2014 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 1.22% | 0.75% |
#20
29
Prev: #49
|
3.5 |
—
|
8,379 | 92.7% |
P
S
|
17,419 | $9,353,132 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 1.21% | 1.09% |
#21
9
Prev: #30
|
1.0 |
—
|
-75,000 | -13.1% |
P
S
|
499,029 | $9,306,891 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 1.18% | 0.91% |
#22
18
Prev: #40
|
3.0 |
—
|
100,332 | 39.2% |
P
S
|
356,534 | $9,020,310 | 2015 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.17% | 1.23% |
#23
1
Prev: #22
|
1.0 |
—
|
-2,707 | -1.1% |
P
S
|
240,868 | $8,962,698 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.16% | — |
#24
Prev: #—
|
4.0 |
—
|
80,400 | — |
NEW
|
80,400 | $8,926,812 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CALL
CYTOKINETICS IN...
|
CALL Option | 1.11% | 2.71% |
#25
18
Prev: #7
|
0.4 |
—
|
-159,300 | -61.4% |
P
S
|
100,000 | $8,519,000 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 1.06% | 1.08% |
#26
5
Prev: #31
|
2.9 |
—
|
215,355 | 40.1% |
P
S
|
752,983 | $8,154,806 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LRCX
LAM RESEARCH CO...
|
Technology | 1.04% | — |
#27
Prev: #—
|
3.9 |
—
|
18,470 | — |
NEW
|
18,470 | $8,003,605 | 2017 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AMAT
APPLIED MATLS I...
|
Technology | 1.04% | — |
#28
Prev: #—
|
3.9 |
—
|
11,040 | — |
NEW
|
11,040 | $7,981,920 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 1.04% | 1.14% |
#29
3
Prev: #26
|
0.4 |
—
|
-89,313 | -26.0% |
P
S
|
254,250 | $7,947,855 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVS
NOVARTIS AG
|
Healthcare | 1.02% | 0.90% |
#30
11
Prev: #41
|
2.9 |
—
|
13,000 | 35.1% |
P
S
|
50,000 | $7,832,904 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
SOLAREDGE TECHN...
|
|
Bond/Debt | 1.01% | 1.10% |
#31
3
Prev: #28
|
1.4 |
—
|
no change | no change |
P
S
|
4,000,000 | $7,747,190 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 1.00% | 0.91% |
#32
7
Prev: #39
|
2.9 |
—
|
94,500 | 29.4% |
P
S
|
416,417 | $7,666,237 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABBV
ABBVIE INC
|
Healthcare | 0.99% | 1.05% |
#33
2
Prev: #35
|
1.4 |
—
|
no change | no change |
P
S
|
30,256 | $7,613,620 | 2014 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 0.98% | 0.93% |
#34
4
Prev: #38
|
2.9 |
—
|
10,000 | 20.6% |
P
S
|
58,600 | $7,530,100 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JNJ
JOHNSON & JOHNS...
|
Healthcare | 0.96% | 1.12% |
#35
8
Prev: #27
|
1.4 |
—
|
no change | no change |
P
S
|
28,831 | $7,322,209 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 0.95% | — |
#36
Prev: #—
|
3.9 |
—
|
196,408 | — |
NEW
|
196,408 | $7,320,126 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMTX
IMMATICS N.V
|
Healthcare | 0.95% | 1.09% |
#37
8
Prev: #29
|
0.9 |
—
|
23,952 | 3.4% |
P
S
|
720,057 | $7,294,177 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVCT
NUVECTIS PHARMA...
|
Healthcare | 0.92% | — |
#38
Prev: #—
|
3.9 |
—
|
382,945 | — |
NEW
|
382,945 | $7,042,359 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PFE
PFIZER INC
|
Healthcare | 0.90% | 0.83% |
#39
6
Prev: #45
|
3.4 |
—
|
100,000 | 53.8% |
P
S
|
286,000 | $6,886,880 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.84% | — |
#40
Prev: #—
|
3.8 |
—
|
176,663 | — |
NEW
|
176,663 | $6,432,300 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 0.83% | 1.17% |
#41
17
Prev: #24
|
0.8 |
—
|
-22,000 | -17.3% |
P
S
|
105,000 | $6,337,800 | 2016 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 0.82% | 0.46% |
#42
25
Prev: #67
|
2.3 |
—
|
64,500 | 15.4% |
P
S
|
483,747 | $6,308,061 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 0.76% | 0.67% |
#43
11
Prev: #54
|
2.3 |
—
|
16,500 | 7.7% |
P
S
|
230,834 | $5,858,567 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVO
NOVO-NORDISK A ...
|
Healthcare | 0.75% | 0.70% |
#44
7
Prev: #51
|
1.3 |
—
|
no change | no change |
P
S
|
120,677 | $5,785,255 | 2019 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.75% | 0.95% |
#45
8
Prev: #37
|
0.3 |
—
|
-40,500 | -26.4% |
P
S
|
112,765 | $5,722,824 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRLD
PRELUDE THERAPE...
|
Healthcare | 0.71% | 0.30% |
#46
33
Prev: #79
|
3.3 |
—
|
461,493 | 82.7% |
P
S
|
1,019,832 | $5,435,705 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GSK
GSK PLC
|
Healthcare | 0.70% | 1.07% |
#47
14
Prev: #33
|
0.8 |
—
|
-20,000 | -16.4% |
P
S
|
102,000 | $5,346,840 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FBRX
FORTE BIOSCIENC...
|
Healthcare | 0.69% | 0.76% |
#48
1
Prev: #47
|
2.8 |
—
|
64,709 | 35.0% |
P
S
|
249,693 | $5,305,976 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIOA
BIOAGE LABS INC
|
Healthcare | 0.68% | 0.24% |
#49
36
Prev: #85
|
3.3 |
—
|
127,153 | 147.0% |
P
S
|
213,671 | $5,237,076 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 0.68% | 0.74% |
#50
Prev: #50
|
1.3 |
—
|
no change | no change |
P
S
|
94,265 | $5,184,575 | 2018 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 123 holdings